Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osteonecrosis of the jaw and bevacizumab therapy.

× No keyword cloud information.

15 in total

1. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

Authors:
Journal: J Oral Maxillofac Surg Date: 2007-03 Impact factor: 1.895

Review 2. Osteonecrosis of the jaw: who gets it, and why?

Authors: Ian R Reid
Journal: Bone Date: 2008-10-07 Impact factor: 4.398

Review 3. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review.

Authors: Soulafa A Almazrooa; Sook-Bin Woo
Journal: J Am Dent Assoc Date: 2009-07 Impact factor: 3.634

4. Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Authors: Jeanny B Aragon-Ching; Yang-Min Ning; Clara C Chen; Lea Latham; Jean-Pierre Guadagnini; James L Gulley; Philip M Arlen; John J Wright; Howard Parnes; William D Figg; William L Dahut
Journal: Cancer Invest Date: 2009-02 Impact factor: 2.176

Review 5. Exploring the anti-tumour activity of bisphosphonates in early breast cancer.

Authors: M C Winter; I Holen; R E Coleman
Journal: Cancer Treat Rev Date: 2008-08 Impact factor: 12.111

Review 6. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.

Authors: Matthew R Allen; David B Burr
Journal: J Oral Maxillofac Surg Date: 2009-05 Impact factor: 1.895

Review 7. Epidemiology of bisphosphonate-related osteonecrosis of the jaws: the utility of a national registry.

Authors: Richard Gliklich; Jerome Wilson
Journal: J Oral Maxillofac Surg Date: 2009-05 Impact factor: 1.895

8. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors: Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal: J Bone Miner Res Date: 2007-10 Impact factor: 6.741

Review 9. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.

Authors: Beatrice J Edwards; Mrinal Gounder; June M McKoy; Ian Boyd; Mathew Farrugia; Cesar Migliorati; Robert Marx; Salvatore Ruggiero; Meletios Dimopoulos; Dennis W Raisch; Seema Singhal; Ken Carson; Eniola Obadina; Steve Trifilio; Dennis West; Jayesh Mehta; Charles L Bennett
Journal: Lancet Oncol Date: 2008-12 Impact factor: 41.316

10. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis.

Authors: Davide Mauri; Antonis Valachis; Ilias P Polyzos; Nikolaos P Polyzos; Konstantinos Kamposioras; Lorenzo L Pesce
Journal: Breast Cancer Res Treat Date: 2009-06-12 Impact factor: 4.872

11 in total

1. Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Authors: Jason Fangusaro; Sridharan Gururangan; Regina I Jakacki; Sue C Kaste; Stewart Goldman; Ian F Pollack; James M Boyett; Larry E Kun
Journal: J Clin Oncol Date: 2012-11-19 Impact factor: 44.544

2. Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro.

Authors: A M Pabst; M Krüger; T Ziebart; C Jacobs; C Walter
Journal: Clin Oral Investig Date: 2015-01-16 Impact factor: 3.573

3. The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay.

Authors: A M Pabst; M Krüger; K Sagheb; T Ziebart; C Jacobs; S Blatt; E Goetze; C Walter
Journal: Clin Oral Investig Date: 2016-05-12 Impact factor: 3.573

Review 4. Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors: Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal: Ann N Y Acad Sci Date: 2011-02 Impact factor: 5.691

5. Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay.

Authors: A M Pabst; T Ziebart; M Ackermann; M A Konerding; C Walter
Journal: Clin Oral Investig Date: 2013-07-28 Impact factor: 3.573

6. Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Authors: Jason Fangusaro; Sridharan Gururangan; Tina Young Poussaint; Roger E McLendon; Arzu Onar-Thomas; Katherine E Warren; Shengjie Wu; Roger J Packer; Anu Banerjee; Richard J Gilbertson; Regina Jakacki; Amar Gajjar; Stewart Goldman; Ian F Pollack; Henry S Friedman; James M Boyett; Larry E Kun; Maryam Fouladi
Journal: Cancer Date: 2013-09-19 Impact factor: 6.860

7. Meth Mouth-A Growing Epidemic in Dentistry?

Authors: Andreas Pabst; Juan Carlos Castillo-Duque; Axel Mayer; Marcus Klinghuber; Richard Werkmeister
Journal: Dent J (Basel) Date: 2017-10-30

Review 8. Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview.

Authors: Andreas Max Pabst; Maximilian Krüger; Sebastian Blatt; Thomas Ziebart; Roman Rahimi-Nedjat; Elisabeth Goetze; Christian Walter
Journal: Dent J (Basel) Date: 2016-12-26

Review 9. The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes.

Authors: Amerigo Giudice; Alessandro Antonelli; Emanuela Chiarella; Francesco Baudi; Tullio Barni; Anna Di Vito
Journal: Pharmaceuticals (Basel) Date: 2020-11-25

Review 10. Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors: A Eguia; L Bagán-Debón; F Cardona
Journal: Med Oral Patol Oral Cir Bucal Date: 2020-01-01